Latest Education News

3P Learning reports a statutory net profit of $9.9 million and a 26% rise in underlying EBITDA to $19.5 million for FY26, declaring a 3.52 cent dividend after more than a decade.

Janison Education Group posted a 3% revenue rise to $48.1 million in FY26, underpinned by international contract expansion and AI innovation, despite margin pressure from onboarding costs.

Cedar Woods Properties delivered a record $65.6 million net profit after tax in FY26, up 36%, supported by strong presales and disciplined capital management, while targeting 15% NPAT growth in FY27.

Dalrymple Bay Infrastructure reported a 14.2% rise in net profit for H1 2026, underpinned by higher terminal charges and ongoing capital investment, while raising distribution guidance by 8.5%.

TALi Digital is acquiring Datasphere Analytics to access cutting-edge memristive in-memory computing technology, aiming to enhance its AI-driven education platform. The company is concurrently raising $3.3 million to fund this strategic move and ongoing operations.

Janison Education Group has landed a landmark subcontract with NFER to deliver Scotland's national standardised assessments, marking its first UK government contract and a strategic expansion beyond ANZ.

Memphasys has cleared a key regulatory hurdle in Vietnam for its Felix™ System, prompting a significant first commercial cartridge order and marking early clinical success in a fast-growing fertility market.

IDP Education’s FY26 results reveal a sharp 75% plunge in net profit as student volumes shrink, but the company pushes ahead with a $32 million cost-cutting transformation and AI investments.

NextEd Group navigated a tough international education market in FY26, boosting underlying EBITDA by 7% to $15.3 million even as revenue fell 6.7%. A $13 million goodwill impairment weighed on net losses, but ongoing cost discipline and vocational course growth underpin a resilient platform.

WAM Leaders Limited (ASX:WLE) delivered a stellar FY2026 with net profit after tax soaring 153.5% to AUD 161.8 million, driven by a 14% investment portfolio gain that outpaced the ASX 200 by 7.9%. The company declared a fully franked full year dividend of 9.6 cents per share, maintaining a strong yield amid ongoing capital raising.

OncoSil Medical has won FDA Humanitarian Device Exemption approval for its OncoSil™ device to treat distal cholangiocarcinoma, opening a US market estimated at A$80 million annually.

Audinate Group Limited reported a 15% revenue increase driven by its expanding Dante ecosystem and Iris acquisition, but underlying EBITDA losses widened amid restructuring and investment costs.